Extended-Spectrum β-Lactamase- Producing Gram-Negative Bacterial Infections in Severely Ill COVID-19 Patients Admitted in a National Referral Hospital, Kenya
dc.contributor.author | Mutua, Jeniffer Munyiva | |
dc.contributor.author | Mwaniki, John Njeru | |
dc.contributor.author | Musyoki, Abednego Moki | |
dc.date.accessioned | 2023-06-27T08:02:14Z | |
dc.date.available | 2023-06-27T08:02:14Z | |
dc.date.issued | 2023 | |
dc.description | Article | en_US |
dc.description.abstract | Bacterial infections in COVID-19 patients, especially those caused by multidrug-resistant gram-negative strains, are associated with increased morbidity, hospital stay and mortality. However, there is limited data on the epidemiology of extended-spectrum β-lactamase (ESBL)-producing bacteria in COVID-19 patients. Here, we assessed the prevalence and the factors associated with ESBL-producing gram-negative bacteria (GNB) infections among severely ill laboratory-confirmed COVID-19 patients admitted at Kenyatta National Hospital (KNH), Kenya. | en_US |
dc.description.sponsorship | Kenyatta National Hospital (KNH) Medical Research and Programs. | en_US |
dc.identifier.citation | Mutua, J. M., Mwaniki, J. N., & Musyoki, A. M. (2023). Extended-spectrum β-lactamase-producing gram-negative bacterial infections in severely ill COVID-19 patients admitted in a national referral hospital, Kenya. | en_US |
dc.identifier.uri | https://doi.org/10.21203/rs.3.rs-2743275/v1 | |
dc.identifier.uri | http://ir-library.ku.ac.ke/handle/123456789/25993 | |
dc.language.iso | en | en_US |
dc.publisher | Research Square | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | multidrug resistance | en_US |
dc.subject | ESBL-producing | en_US |
dc.subject | Gram-negative bacteria | en_US |
dc.title | Extended-Spectrum β-Lactamase- Producing Gram-Negative Bacterial Infections in Severely Ill COVID-19 Patients Admitted in a National Referral Hospital, Kenya | en_US |
dc.type | Article | en_US |